INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Exelixis, Inc. - EXEL

On this news, Exelixis's stock price fell $7.45 per share, or 16.78%, to close at $36.94 per share on July 29, 2025. [Click here for information about joining the class action] On July 28, 2025, Exelixis issued a press release "report[ing] financial results for the second quarter of 2025" and "provid[ing] an update on progress toward achieving key corporate objectives, and outlined its commercial, clinical and pipeline development milestones." Among other items, Exelixis reported that net product revenues f ...